Results 171 to 180 of about 200,279 (211)
Some of the next articles are maybe not open access.
The biology and chemistry of hyperlipidemia
Bioorganic & Medicinal Chemistry, 2007AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Kishor S, Jain +3 more
openaire +2 more sources
JAMA: The Journal of the American Medical Association, 1974
The treatment of hyperlipidemia is desirable, especially in patients with a family history of premature ischemic heart disease, but only after the specific type of hyperlipoproteinemia has been determined. Secondary causes of hyperlipoproteinemia should be sought and eliminated.
openaire +2 more sources
The treatment of hyperlipidemia is desirable, especially in patients with a family history of premature ischemic heart disease, but only after the specific type of hyperlipoproteinemia has been determined. Secondary causes of hyperlipoproteinemia should be sought and eliminated.
openaire +2 more sources
Medical Clinics of North America
Significant advances in atherosclerotic cardiovascular (ASCVD) risk stratification and treatment have occurred over the past 10 years. While the lipid panel continues to be the basis of risk estimation, imaging for coronary artery calcium is now widely used in estimating risk at the individual level.
Jennifer, Wright, Savitha, Subramanian
openaire +2 more sources
Significant advances in atherosclerotic cardiovascular (ASCVD) risk stratification and treatment have occurred over the past 10 years. While the lipid panel continues to be the basis of risk estimation, imaging for coronary artery calcium is now widely used in estimating risk at the individual level.
Jennifer, Wright, Savitha, Subramanian
openaire +2 more sources
Archives of Pediatrics & Adolescent Medicine, 1977
C, Chantler, R, Counahan, M, El-Bishti
openaire +2 more sources
C, Chantler, R, Counahan, M, El-Bishti
openaire +2 more sources
Hyperlipidemia in the Nephrotic Syndrome
American Journal of Kidney Diseases, 1988H YPERLIPIDEMIA may be a severe and refractory manifestation of the nephrotic syndrome, responsible for accelerated atherogenesis. Nephrotic hyperlipidemia results from both the increased hepatic synthesis of lipids and their decreased rate of removal from the circulation.
openaire +3 more sources
Interpretation of Hyperlipidemias
CRC Critical Reviews in Clinical Laboratory Sciences, 1972W R, Harlan, W A, Shaw
openaire +2 more sources